Alloplex’s Abstract (15740) ‘Potent Tumor Organoid Infiltration and Killing by PBMC-Derived Effector Cells’ was accepted by SITC for a poster presentation at the 2021 annual meeting.
Download the poster and media kit.
Are you an analyst, member of the media, business development professional or investor who’d like to receive our future news from Alloplex? Please email your contact details to media@alloplexbio.com
(Subject: News request).
As the largest conference focused solely on cancer immunotherapy, the Society for Immunotherapy of Cancer (‘SITC’)’s annual meeting and pre-conference programs provides international leaders from academia, regulatory and government agencies, as well as industry representatives with a multidisciplinary educational and interactive environment focused on improving outcomes for all cancer patients.